Intellectus Partners, LLC Nuvation Bio Inc. Transaction History

Intellectus Partners, LLC

$361 Million
Q2 2024

A detailed history of Intellectus Partners, LLC transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Intellectus Partners, LLC holds 246,905 shares of NUVB stock, worth $577,757. This represents 0.2% of its overall portfolio holdings.

Number of Shares

246,905

Previous 234,440 5.32%

Holding current value

$577,757

Previous $853,000 15.59%

% of portfolio

0.2%

Previous 0.23%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 18, 2024	BUY	$2.58 - $3.69 $32,159 - $45,995	12,465 Added 5.32%	246,905 $720,000
Q1 2024 May 03, 2024	BUY	$1.46 - $3.97 $77,844 - $211,672	53,318 Added 29.44%	234,440 $853,000
Q4 2023 Feb 05, 2024	SELL	$0.96 - $1.53 $18,340 - $29,230	-19,105 Reduced 9.54%	181,122 $273,000
Q3 2023 Oct 25, 2023	BUY	$1.26 - $2.1 $879 - $1,465	698 Added 0.35%	200,227 $268,000
Q2 2023 Jul 31, 2023	BUY	$1.56 - $1.84 $27,861 - $32,862	17,860 Added 9.83%	199,529 $359,000
Q1 2023 May 04, 2023	SELL	$1.6 - $2.48 $2,400 - $3,720	-1,500 Reduced 0.82%	181,669 $301,000
Q4 2022 Feb 02, 2023	BUY	$1.68 - $2.5 $15,494 - $23,057	9,223 Added 5.3%	183,169 $351,000
Q3 2022 Nov 14, 2022	BUY	$0.29 - $4.04 $3,677 - $51,227	12,680 Added 7.86%	173,946 $390,000
Q2 2022 Aug 12, 2022	BUY	$3.24 - $5.85 $39,502 - $71,323	12,192 Added 8.18%	161,266 $523,000
Q1 2022 May 16, 2022	BUY	$4.6 - $8.83 $40,259 - $77,280	8,752 Added 6.24%	149,074 $784,000
Q4 2021 Feb 14, 2022	SELL	$7.75 - $10.05 $109,313 - $141,755	-14,105 Reduced 9.13%	140,322 $1.19 Million
Q3 2021 Nov 16, 2021	BUY	$7.78 - $10.0 $264,481 - $339,950	33,995 Added 28.23%	154,427 $1.54 Million
Q2 2021 Aug 13, 2021	BUY	$9.22 - $14.48 $193,693 - $304,195	21,008 Added 21.13%	120,432 $1.12 Million
Q1 2021 May 17, 2021	BUY	$9.0 - $14.57 $894,816 - $1.45 Million	99,424 New	99,424 $1.04 Million

Others Institutions Holding NUVB

# of Institutions

152

Shares Held

123M

Call Options Held

9.7K

Put Options Held

6.5K

View Full List

About Nuvation Bio Inc.

Ticker NUVB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 217,244,000
Market Cap $508M
Description
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...

More about NUVB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Intellectus Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Intellectus Partners, LLC with notifications on news.

Account

Intellectus Partners, LLC Nuvation Bio Inc. Transaction History